Skip to main content
. Author manuscript; available in PMC: 2024 Mar 1.
Published in final edited form as: J Neurochem. 2022 Dec 7;164(5):613–623. doi: 10.1111/jnc.15730

Figure 4: Oxytocin (OT) administration does not alter methylphenidate (MP)-induced increases in phasic nucleus accumbens shell (NAS) dopamine (DA).

Figure 4:

Analysis of fast scan cyclic voltammetry (FSCV) results of evoked NAS DA at baseline/control, 10 min after saline or OT (2mg/kg; i.p.) and 10 min after increasing doses of methylphenidate (MP) (0.1, 0.32, 1.0 mg/kg; i.v.). Data are shown as the average of each animal’s results normalized to their baseline for (A) Maximum evoked DA (DAmax), (B) area under the curve (AUC), (C) t1/2 throughout the experimental paradigm and error bars indicate SEM (n=6 rats for each).